---
ontology: mondo
issue_number: 9963
pr_number: 10222
eval_repo_pr: 484
agent: std_copilot_son45
model: claude-sonnet-4.5
runtime: copilot
agent_config_tag: v3
case_type: new_term
difficulty: medium
f1: 0.308
precision: 0.4
recall: 0.25
jaccard: 0.182
outcome: partial_success
failure_modes: [over_editing, wrong_pattern]
reviewed_by: claude-opus-4.7
reviewed_at: 2026-05-15
---

## Summary

A re-run of the same claude-sonnet-4.5/copilot configuration as eval PR #522, producing a byte-identical diff (same blob `a33095d`): the spectrum term is created, both requested children re-parented, RNU12 gene axiom added, and the missing `has_material_basis_in_germline_mutation_in HGNC:19380` added to SCAR33. It carries the same defects — an invalid `intersection_of: MONDO:0700096 ! human disease` logical definition and an invalid `dcterms:creator` value. F1=0.308 is depressed by the placeholder-vs-canonical ID artifact plus extra synonyms, but the logical-definition error is a genuine correctness problem.

## Strengths

- Correct ClinGen label; reasonable definition citing affiliation 40060 and `PMID:39802771`.
- Both requested children re-parented additively; existing parents preserved.
- Added the missing RNU12 gene relationship to `MONDO:0859360` SCAR33 — matches a substantive gold edit.

## Issues

- Invalid logical definition: `intersection_of: MONDO:0700096 ! human disease` + the RNU12 axiom — malformed genus for a gene-series term and inconsistent with the asserted parents; gold has no `intersection_of`.
- Invalid provenance: `property_value: http://purl.org/dc/terms/creator https://clinicalgenome.org/affiliation/40060/` (gold uses an ORCID).
- Over-editing of synonyms: child disease names plus "CDAGS syndrome" added as `RELATED` synonyms; not in gold.
- Did not reproduce the gold ClinGen EXACT synonym with the `OMO:0002001` qualifier.
- Parented under both `hereditary disease` and `syndromic disease`; gold kept only `hereditary disease`.
- Did not add the `IAO:0000233` issue link to the two child stanzas (gold did). No PR/issue comment captured.
